X4 Pharmaceuticals announced inducement awards on August 12 and August 14, 2025, under the 2019 Inducement Equity Incentive Plan. The awards on August 12 included options for 4,250,718 shares of X4's common stock each for Dr. Adam Craig and John Volpone, and 2,833,812 shares for David Kirske. On August 14, additional awards were given to the same individuals: Dr. Craig and Mr. Volpone received options for 529,201 shares each, while Mr. Kirske received options for 352,800 shares. These awards are aimed at improving the lives of individuals with rare immune system diseases.